International Journal of Radiation Biology · 2010 · 35 citations · 40 references
MedicineCell BiologyNuclear MedicineRadiation BiophysicsRadiation DosimetryRadiobiologyBiological Effects Of RadiationCellular Radiation ResponseRadiation BiologyRadiation SensitivityRadiation TherapyRelative Biological EffectivenessCell Survival AssaysCellular Radiation DamageCellular RadiosensitivityClonogenic Survival AssaysDouble-strand Dna BreaksPulsed-field Gel ElectrophoresisRadiation-induced Dna DamageRadionuclide-induced Dna Damage
PURPOSE: To investigate cell cycle effects and relative biological effectiveness (RBE) of α-particles from the clinically relevant radionuclide Astatine-211 ((211)At), using X-rays as reference radiation. Double-strand breaks (DSB), non-DSB clusters containing oxidised purines and clonogenic survival were investigated. MATERIALS AND METHODS: Asynchronous V79-379A fibroblasts or cells synchronised with mimosine in G1, early, mid and late S phase or in mitosis were irradiated with X-rays (100 kV(p)) or (211)At (mean linear energy transfer (LET) 110 keV/μm). Induction of DSB and clusters was determined using pulsed-field gel electrophoresis with fragment analysis. Cell survival was obtained with the clonogenic assay. RESULTS: In asynchronous cells RBE for DSB- and cluster-induction was 3.5 and 0.59, respectively. RBE for 37% cell survival was 8.6. In different cell cycle phases RBE varied from 1.8-3.9 for DSB and 3.1-7.9 for 37% survival (survival at 2 Gy was 6.9-38 times lower after α-irradiation). (211)At induced 6 times more DSB and X-rays induced 11 times more DSB in mitotic cells with highly compacted chromatin relative G1. CONCLUSIONS: The radio-response is cell cycle dependent and differs between proliferating and non-cycling cells for both low- and high-LET radiation, resulting in a variation in RBE of α-particles between 1.8 and 8.6.
40
Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle
Kai Rothkamm, Inès Krüger, Larry H. Thompson et al. · Molecular and Cellular Biology · 2003 · 1.2K citations · Full text
Håkan Andersson, Elin Cederkrantz, Tom Bäck et al. · Journal of Nuclear Medicine · 2009 · 288 citations · Full text
Medicine, Oncology, Pharmacokinetics +17